← Companies|Vingroup Biotech
Vi

Vingroup Biotech

Hanoi VNFounded 2018500 employees
Private CapbiotechPrivateInfectious Disease
Platform: Vietnamese Biotech
Market Cap
N/A
All Drugs
3
Clinical Trials
5
Failed / Terminated
0
FDA Approved
1
Drug Pipeline (3 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
VIN-2751VIN-2751Phase 2/31Gene EditingPARPBiTEMDDSchizophrenia
VIN-1694VIN-1694Approved3mAbAuroraAIL-13iEpilepsyFSGS
VIN-3660VIN-3660Phase 21MultispecificBTKBiTECeliac
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)
2028-01-06
VIN-1694 Ph3 Readout
Epilepsy
Ph3 Readout
2030-05-16
VIN-1694 Ph3 Readout
FSGS
Ph3 Readout
2030-11-05
VIN-2751 Ph3 Readout
MDD
Ph3 Readout